Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.56 - $2147.95 $7,840 - $30.1 Million
14,000 Added 8.27%
183,200 $99,000
Q2 2022

Aug 12, 2022

SELL
$0.48 - $1.12 $6,432 - $15,008
-13,400 Reduced 7.34%
169,200 $100,000
Q1 2022

May 13, 2022

SELL
$0.85 - $1.27 $19,550 - $29,210
-23,000 Reduced 11.19%
182,600 $184,000
Q4 2021

Feb 11, 2022

BUY
$1.13 - $2.26 $31,643 - $63,286
28,003 Added 15.77%
205,600 $234,000
Q3 2021

Nov 12, 2021

BUY
$2.12 - $4.6 $260,117 - $564,406
122,697 Added 223.49%
177,597 $391,000
Q2 2021

Aug 13, 2021

BUY
$3.53 - $5.98 $193,797 - $328,302
54,900 New
54,900 $231,000

About Nuwellis, Inc.


  • Ticker NUWE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,531,600
  • Market Cap $55.8M
  • Description
  • Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex ...
More about NUWE
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.